Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)
5.12
+0.06 (1.19%)
May 23, 2025, 2:45 PM CST
SHE:000908 Revenue
In the year 2024, Hunan Jingfeng Pharmaceutical had annual revenue of 416.03M CNY, down -36.67%. Hunan Jingfeng Pharmaceutical had revenue of 100.11M in the quarter ending March 31, 2025, a decrease of -0.46%.
Revenue
416.03M
Revenue Growth
-36.67%
P/S Ratio
10.70
Revenue / Employee
727.33K
Employees
572
Market Cap
4.45B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 416.03M | -240.86M | -36.67% |
Dec 31, 2023 | 656.89M | -183.76M | -21.86% |
Jan 1, 2023 | 840.66M | 29.47M | 3.63% |
Jan 1, 2022 | 811.18M | -66.74M | -7.60% |
Dec 31, 2020 | 877.92M | -466.11M | -34.68% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |